Abstract
Introduction

Alzheimer disease (AD) is a devastating neurodegenerative disease characterized by a progressive decline in memory and cognitive functions such as language and perception
. It affects mostly elderly people and appears both sporadically (accounting for about 95% of all cases) and in familiar autosomal dominant (FAD) form [2, 3] . AD is characterized by two brain lesions, intraneuronal fibrillary tangles and extracellular amyloid plaques [4, 5] . [6] [7] [8] . The major constituent of the amyloid plaques is a hydrophobic 39-43 amino acid peptide named amyloid-␤ peptide (A␤), a cleavage product of the much larger transmembrane protein, amyloid precursor protein (APP) encoded by a single gene on chromosome 21 [9] . A␤ is generated from the C-terminal end of APP by the sequential action of ␤-and ␥-secretases [10] . Amyloid formation is generally associated with the clinical manifestations of AD and the A␤ cascade hypothesis is the main pathogenic model of AD [11] . Almost all gene mutations linked to the early-onset FAD cases are associated with deregulated metabolism of APP resulting in enhancement of production of A␤ or increase of A␤42/40 ratio [12] . Although the aetiology of sporadic AD is largely unknown, accumulating data suggest that mitochondrial dysfunction and oxidative stress occur in brain as well as in peripheral tissues of AD patients [13] . Mitochondria [64, 65] . Moreover, in response to decreased mitochondrial membrane potential parkin is re-localized from cytosol to mitochondria, which results in elimination of mitochondria by autophagosomes [66] . All together the changes in intracellular homeostasis during the initial course of AD can potentially increase mitochondrial APP targeting, resulting in mitochondrial Fig. 1 APP is [67] , the proteolysis of proteins within the matrix or intermembrane space [68] , and proteasome-dependent outer mitochondrial membrane-associated degradation [69] . Careful balance between mitochondrial fission and fusion ensures the mitochondrial quality; however, mitochondria lacking electrochemical potential for extended periods will be selectively cleared through steady-state autophagy, or mitophagy [66, 70] [71, 72] 
Neurofibrillary tangles are composed of aggregated hyperphosphorylated protein. The role of aggregated in neurodegeneration is still controversial, as evidence points to either a toxic or protective role in the disease
. Furthermore, overexpression of APP in neuroblastoma cell lines displayed fragmentation and abnormal distribution of mitochondria caused by an imbalance of the mitochondrial fission and fusion system, leading to mitochondrial and neuronal dysfunction [72]. This indicates that the balance between mitochondrial fission and fusion can be affected by mitochondrial accumulation of APP or A␤, or that a change in the fission and fusion balance towards increased fission during AD progression could result in mitochondrial APP and A␤ accumulation.
Mitochondrial protein turnover is a balance between protein synthesis inside the organelle, import of nuclear encoded proteins from cytosol and protein degradation by mitochondrial proteases. Several proteases have been identified and extensively studied in mitochondria. For example, the mitochondrial protease HtrA2/Omi has been studied in connection to APP turnover [73, 74] . HtrA2/Omi was able to cleave APP in vitro, inside mitochondria in vivo [73] as well as during ER-associated APP degradation [74] . [75, 76] . However, animal studies using mice with a targeted deletion of the HtrA2/Omi gene [77] as well as motor neuron degeneration 2 mice (Mnd2) [78] [80, 81] . HtrA2/Omi protease activity is regulated through serine phosphorylation having stimulating (Ser142) [82] or inhibitory (Ser212) [83] [82, [84] [85] [86] . Interestingly HtrA2/Omi interacts with presenilin-1, a catalytic subunit of the ␥-secretase that cleaves APP to produce A␤ peptide [86] .
HtrA2/Omi is a serine protease located in the intermembrane space of mitochondria. During cell death HtrA2/Omi translocates from intermembrane space to cytosol and enhances apoptosis via cleavage of inhibitory apoptosis proteins and subsequent activation of caspases
It remains to be tested if the inhibition of the APP accumulation in mitochondrial import channels or increased proteolysis of APP would protect cells from mitochondria-mediated injury and potentially slow down AD progression.
Mitochondria as a target and mediator of A␤ toxicity
We and others have shown that A␤ is accumulating in mitochondria from post-mortem AD brain, living patients with cortical plaques and TgAPP mice [87] [88] [89] [90] . In TgAPP mice mitochondrial A␤ accumulation occurs prior to plaque formation, indicating that this is an early event in the pathogenesis [87] . Even though both APP [54] and ␥-secretase complexes [91] 
have been detected in mitochondria it is not likely that A␤ is produced locally in mitochondria. The reason is that the import of APP is arrested due to an acidic domain at amino acids 220-290 leaving the A␤-region
outside the membrane. Since ␥-secretase cleaves its substrates by regulated intramembrane proteolysis such localization of APP excludes it as a ␥-secretase substrate in mitochondria. Therefore, A␤ found in AD mitochondria must have been taken up. We decided to investigate these uptake mechanisms using isolated mitochondria treated with A␤ in the absence or presence of antibodies or inhibitors directed to various mitochondrial translocases and pores [90] . The uptake of A␤ was not affected by the presence of antibodies directed towards the voltage-dependent anion channel nor in the presence of cyclosporine A which is an inhibitor of the mitochondrial permeability transition pore (mPTP). Interestingly, import of both A␤1-40 and A␤1-42 was prevented when import competent mitochondria were pre-incubated with antibodies directed towards proteins of the TOM complex, i.e. Tom20, Tom40, Tom70 (Fig. 2) . A␤ import was not affected by the addition of valinomycin, an ionophore which cause depolarization of the mitochondrial inner membrane, indicating that the A␤ import was not dependent on the mitochondrial membrane potential. After import A␤ was mostly localized to mitochondrial cristae and associated with the inner membrane fraction. It was earlier reported that A␤ co-localizes with the mitochondrial matrix protein Hsp60 in mouse and human samples [87] . One explanation to this discrepancy might be that in our in vitro assay we studied A␤ localization after 30 min. of import, whereas Caspersen et [88] . ABAD is localized to the mitochondrial matrix and has an essential physiological role in mitochondria (Fig. 2) [104] [105] [106] . IDE is also located on chromosome 10 (10q) and genetic association between single nucleotide polymorphisms (SNPs) in IDE and late onset of AD has been reported [107] . In contrast to IDE, hPreP does not cleave insulin despite the fact that the overall 3D structure of IDE is highly similar to PreP [108] . However, there exist differences that may explain varying cleavage specificity [109] . 3D structural model of hPreP generated from the 3D structure of AtPreP [97, 101] [110] . Intracellular A␤42 has been shown to accumulate in intracellular multivesicular bodies [111] and it is possible that A␤ leaking from these vesicles could reach the mitochondria. Moreover, in our confocal microscopy analysis fluorescent A␤1-40 applied extracellulary is taken up by the cells and later partly localized to mitochondria [90] . Accordingly, Saavedra et 
